Your Monday Briefing
[ad_1] Who will get entry to Merck’s new antiviral tablet? Molnupiravir, an antiviral treatment made by Merck, may herald a not-too-distant future when a simple pill could keep people infected with the coronavirus from dying or falling severely unwell. The drug is simple to distribute and might be taken at residence. Trial outcomes confirmed it … Read more